A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
Condition: Keratosis, Actinic Interventions: Drug: Tirbanibulin (Klisyri®) 10 mg/g ointment; Drug: Diclofenac Sodium 3% Gel Sponsor: Almirall, S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials